Literature DB >> 7878528

Results of pancreaticoduodenectomy for ampullary carcinoma and analysis of prognostic factors for survival.

J H Allema1, M E Reinders, T M van Gulik, D J van Leeuwen, P C Verbeek, L T de Wit, D J Gouma.   

Abstract

BACKGROUND: Results of pancreaticoduodenectomy for ampullary carcinoma were evaluated, and prognostic factors for survival were analyzed.
METHODS: During the period from 1984 to 1992 67 patients underwent subtotal or total pancreaticoduodenectomy for ampullary carcinoma. All clinicopathologic data and their influence on survival were studied.
RESULTS: Subtotal pancreaticoduodenectomy was performed in 62 of 67 patients with a mortality of 6% and a morbidity of 65%; the remaining five patients underwent total pancreaticoduodenectomy. Intraabdominal infection was the most important complication. Resection margins were tumor free in 75% of 67 patients. The overall 5-year survival was 50%. Survival was significantly influenced by the involvement of resection margins. After resection with involved margins 5-year survival was 15% and 60% after resection with free margins (p < 0.001). Tumor size, lymph node involvement, and differentiation grade had limited and not significant influence on survival.
CONCLUSIONS: Subtotal pancreaticoduodenectomy is the type of resection of first choice for ampullary carcinoma. Involvement of resection margins was the strongest prognostic factor for survival. Patients with a tumor size larger than 2 cm, with lymph node involvement, or with a poorly differentiated tumor still had a 5-year survival rate greater than 40%. Patients with involved margins might be candidates for studies on adjuvant therapy.

Entities:  

Mesh:

Year:  1995        PMID: 7878528     DOI: 10.1016/s0039-6060(05)80197-7

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  47 in total

1.  Is local resection adequate for T1 stage ampullary cancer?

Authors:  Albert Amini; John T Miura; Thejus T Jayakrishnan; Fabian M Johnston; Susan Tsai; Kathleen K Christians; T Clark Gamblin; Kiran K Turaga
Journal:  HPB (Oxford)       Date:  2014-11-14       Impact factor: 3.647

2.  Carcinoma of the ampulla of Vater: prognostic factors after curative surgery: a series of 45 cases.

Authors:  A Dorandeu; J L Raoul; F Siriser; N Leclercq-Rioux; M Gosselin; E D Martin; M P Ramée; B Launois
Journal:  Gut       Date:  1997-03       Impact factor: 23.059

3.  Management of ampullary lesions.

Authors:  George W Dittrick; Damien B Mallat; Jeffrey P Lamont
Journal:  Curr Treat Options Gastroenterol       Date:  2006-09

4.  Defining the role of adjuvant external beam radiotherapy on resected adenocarcinoma of the ampulla of vater.

Authors:  John T Miura; Thejus T Jayakrishnan; Albert Amini; Fabian M Johnston; Susan Tsai; Beth Erickson; Edward J Quebbeman; Kathleen K Christians; Douglas B Evans; T Clark Gamblin; Kiran K Turaga
Journal:  J Gastrointest Surg       Date:  2014-08-27       Impact factor: 3.452

5.  Impact of lymph node metastasis on survival in patients with pathological T1 carcinoma of the ampulla of Vater.

Authors:  Hiroshi Terasawa; Kazuhisa Uchiyama; Masaji Tani; Manabu Kawai; Takeshi Tsuji; Katsuyoshi Tabuse; Yasuhito Kobayashi; Katsutoshi Taniguchi; Hiroki Yamaue
Journal:  J Gastrointest Surg       Date:  2006-06       Impact factor: 3.452

6.  Tumor budding as a strong prognostic indicator in invasive ampullary adenocarcinomas.

Authors:  Nobuyuki Ohike; Ipek Coban; Grace E Kim; Olca Basturk; Takuma Tajiri; Alyssa Krasinskas; Sudeshna Bandyopadhyay; Toshio Morohoshi; Yuki Shimada; David A Kooby; Charles A Staley; Michael Goodman; N Volkan Adsay; Nazmi Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2010-10       Impact factor: 6.394

7.  Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma.

Authors:  Takeshi Sudo; Yoshiaki Murakami; Kenichiro Uemura; Yasuo Hayashidani; Yasushi Hashimoto; Hiroki Ohge; Fumio Shimamoto; Taijiro Sueda
Journal:  Dig Dis Sci       Date:  2007-12-20       Impact factor: 3.199

8.  Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability.

Authors:  Fausto Sessa; Daniela Furlan; Clementina Zampatti; Ileana Carnevali; Francesca Franzi; Carlo Capella
Journal:  Virchows Arch       Date:  2007-07-26       Impact factor: 4.064

9.  Synchronous adenocarcinoma of the major and minor duodenal papilla.

Authors:  Andre Siqueira Matheus; Jose Jukemura; Andre L Montagnini; Tiago Kunitake; Rosely A Patzina; Jose Eduardo Monteiro da Cunha
Journal:  J Gastrointest Surg       Date:  2007-09-18       Impact factor: 3.452

10.  Determining the Adequate Examined Lymph Node Count in Resected Ampullary Adenocarcinoma-A National Cohort Study.

Authors:  Ibrahim Nassour; Alana Christie; Michael A Choti; John C Mansour; Rebecca M Minter; Patricio M Polanco; Mathew M Augustine; Matthew R Porembka; Xian-Jin Xie; Sam C Wang
Journal:  J Gastrointest Surg       Date:  2018-03-15       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.